Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Búsqueda
Enfermedad de Parkinson y Parkinsonismo Parkinson’s disease & Parkinsonism 2915 artículos Viendo del 1 al 40 de 2915 artículos
Pub MED

Effect of subthalamic nuclei electrical stimulation in the treatment of Parkinson's disease.NUEVO

Tao Y, Liang G.
Cell Biochem Biophys. 2015 Jan;71(1):113-7. doi: 10.1007/s12013-014-0169-0.
Pub MED

Efficacy of adenosine A2A receptor antagonist istradefylline as augmentation for Parkinson's disease: a meta-analysis of randomized controlled trials.NUEVO

Tao Y, Liang G.
Cell Biochem Biophys. 2015 Jan;71(1):57-62. doi: 10.1007/s12013-014-0162-7.
Pub MED

MPTP/MPP+ suppresses activation of protein C in Parkinson's disease.NUEVO

Chen T, Hou R, Li C, Wu C, Xu S.
J Alzheimers Dis. 2015;43(1):133-42. doi: 10.3233/JAD-140126.
Pub MED

Erratum to: Amplitude-oriented exercise in Parkinson's disease: a randomized study comparing LSVT-BIG and a short training protocol.NUEVO

Ebersbach G, Grust U, Ebersbach A, Wegner B, Gandor F, Kühn AA.
J Neural Transm (Vienna). 2015 Feb;122(2):257. doi: 10.1007/s00702-014-1264-5. No abstract available.
Pub MED

A full-brain, bootstrapped analysis of diffusion tensor imaging robustly differentiates Parkinson disease from healthy controls.NUEVO

Skidmore FM, Spetsieris PG, Anthony T, Cutter GR, von Deneen KM, Liu Y, White KD, Heilman KM, Myers J, Standaert DG, Lahti AC, Eidelberg D, Ulug AM.
Neuroinformatics. 2015 Jan;13(1):7-18. doi: 10.1007/s12021-014-9222-9.
Pub MED

Clinical and pathological features of Parkinson's disease.NUEVO

Schneider SA, Obeso JA.
Curr Top Behav Neurosci. 2015;22:205-20. doi: 10.1007/7854_2014_317. Review.
Pub MED

Modeling LRRK2 Pathobiology in Parkinson's Disease: From Yeast to Rodents.NUEVO

Daniel G, Moore DJ.
Curr Top Behav Neurosci. 2015;22:331-68. doi: 10.1007/7854_2014_311. Review.
Pub MED

Viral vector-based models of Parkinson's disease.NUEVO

Van der Perren A, Van den Haute C, Baekelandt V.
Curr Top Behav Neurosci. 2015;22:271-301. doi: 10.1007/7854_2014_310. Review.
Pub MED

Execution of Activities of Daily Living in Persons with Parkinson Disease.NUEVO

Skinner JW, Lee HK, Roemmich RT, Amano S, Hass CJ.
Med Sci Sports Exerc. 2015 Sep;47(9):1906-12. doi: 10.1249/MSS.0000000000000598.
Pub MED

Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration.NUEVO

Sari ES, Koc R, Yazici A, Sahin G, Ermis SS.
J Neuroophthalmol. 2015 Jun;35(2):117-21. doi: 10.1097/WNO.0000000000000203.
Pub MED

Gene therapy for Parkinson's disease: still a hot topic?NUEVO

Kordower JH.
Neuropsychopharmacology. 2015 Jan;40(1):255-6. doi: 10.1038/npp.2014.235. Review. No abstract available.
Pub MED

Adapted step length estimators for patients with Parkinson's disease using a lateral belt worn accelerometer.NUEVO

Sayeed T, Samà A, Català A, Rodríguez-Molinero A, Cabestany J.
Technol Health Care. 2015;23(2):179-94. doi: 10.3233/THC-140882.
Pub MED

Symmetry matched auditory cues improve gait steadiness in most people with Parkinson's disease but not in healthy older people.NUEVO

Brodie MA, Dean RT, Beijer TR, Canning CG, Smith ST, Menant JC, Lord SR.
J Parkinsons Dis. 2015;5(1):105-16. doi: 10.3233/JPD-140430.
Pub MED

Lower Serum Bilirubin and Uric Acid Concentrations in Patients with Parkinson's Disease in China.NUEVO

Qin XL, Zhang QS, Sun L, Hao MW, Hu ZT.
Cell Biochem Biophys. 2015 May;72(1):49-56. doi: 10.1007/s12013-014-0402-x.
Pub MED

Treatment strategies in early and advanced Parkinson disease.NUEVO

Ossig C, Reichmann H.
Neurol Clin. 2015 Feb;33(1):19-37. doi: 10.1016/j.ncl.2014.09.009. Review.
Pub MED

Pathogenic mechanisms of neurodegeneration in Parkinson disease.NUEVO

Mullin S, Schapira AH.
Neurol Clin. 2015 Feb;33(1):1-17. doi: 10.1016/j.ncl.2014.09.010. Review.
Pub MED

Meta-analysis study on the role of bone-derived neurotrophic factor Val66Met polymorphism in Parkinson's disease.NUEVO

Mariani S, Ventriglia M, Simonelli I, Bucossi S, Siotto M, R RS.
Rejuvenation Res. 2015 Feb;18(1):40-7. doi: 10.1089/rej.2014.1612. Review.
Pub MED

Imagine that: elevated sensory strength of mental imagery in individuals with Parkinson's disease and visual hallucinations.NUEVO

Shine JM, Keogh R, O'Callaghan C, Muller AJ, Lewis SJ, Pearson J.
Proc Biol Sci. 2015 Jan 7;282(1798):20142047. doi: 10.1098/rspb.2014.2047.
Pub MED

Abnormal visual contrast acuity in Parkinson's disease.NUEVO

Lin TP, Rigby H, Adler JS, Hentz JG, Balcer LJ, Galetta SL, Devick S, Cronin R, Adler CH.
J Parkinsons Dis. 2015;5(1):125-30. doi: 10.3233/JPD-140470.
Pub MED

Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease.NUEVO

Caviness JN, Hentz JG, Belden CM, Shill HA, Driver-Dunckley ED, Sabbagh MN, Powell JJ, Adler CH.
J Parkinsons Dis. 2015;5(1):117-24. doi: 10.3233/JPD-140480.
Pub MED

Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.NUEVO

Smith KM, Eyal E, Weintraub D; ADAGIO Investigators..
JAMA Neurol. 2015 Jan;72(1):88-95. doi: 10.1001/jamaneurol.2014.2472.
Pub MED

Towards the development of a device to improve the gait of patients suffering from Parkinson's disease.NUEVO

Tsotsolas N.
Adv Exp Med Biol. 2015;822:179. doi: 10.1007/978-3-319-08927-0_19. No abstract available.
Pub MED

Kinesia paradoxa: a challenging Parkinson's phenomenon for simulation.NUEVO

Banou E.
Adv Exp Med Biol. 2015;822:165-77. doi: 10.1007/978-3-319-08927-0_18.
Pub MED

Towards an expert system for accurate diagnosis and progress monitoring of Parkinson's disease.NUEVO

Alexiou A, Psiha M, Vlamos P.
Adv Exp Med Biol. 2015;822:151-64. doi: 10.1007/978-3-319-08927-0_17.
Pub MED

Modeling neural circuits in Parkinson's disease.NUEVO

Psiha M, Vlamos P.
Adv Exp Med Biol. 2015;822:139-47. doi: 10.1007/978-3-319-08927-0_15.
Pub MED

An update on the use of botulinum toxin therapy in Parkinson's disease.NUEVO

Mills R, Bahroo L, Pagan F.
Curr Neurol Neurosci Rep. 2015 Jan;15(1):511. doi: 10.1007/s11910-014-0511-3. Review.
Pub MED

Development of the Tampa Scale of Kinesiophobia for Parkinson's disease: confirmatory factor analysis, reliability, validity and sensitivity to change.NUEVO

Monticone M, Ferrante S, Ambrosini E, Rocca B, Secci C, Foti C.
Int J Rehabil Res. 2015 Jun;38(2):113-20. doi: 10.1097/MRR.0000000000000095.
Pub MED

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.NUEVO

Agalliu I, San Luciano M, Mirelman A, Giladi N, Waro B, Aasly J, Inzelberg R, Hassin-Baer S, Friedman E, Ruiz-Martinez J, Marti-Masso JF, Orr-Urtreger A, Bressman S, Saunders-Pullman R.
JAMA Neurol. 2015 Jan;72(1):58-65. doi: 10.1001/jamaneurol.2014.1973.
Pub MED

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease.NUEVO

Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, Alcalay RN, Marder KS, Clark LN, Gaig C, Tolosa E, Ruiz-Martínez J, Marti-Masso JF, Ferrer I, López de Munain A, Goldman SM, Schüle B, Langston JW, et al.
JAMA Neurol. 2015 Jan;72(1):100-5. doi: 10.1001/jamaneurol.2014.2704.
Pub MED

Fully Automated Assessment of the Severity of Parkinson's Disease from Speech.NUEVO

Bayestehtashk A, Asgari M, Shafran I, McNames J.
Comput Speech Lang. 2015 Jan;29(1):172-185.
Pub MED

Stochastic anomaly detection in eye-tracking data for quantification of motor symptoms in Parkinson's disease.NUEVO

Jansson D, Medvedev A, Axelson H, Nyholm D.
Adv Exp Med Biol. 2015;823:63-82. doi: 10.1007/978-3-319-10984-8_4.
Pub MED

Effects of endurance exercise training on the motor and non-motor features of Parkinson's disease: a review.NUEVO

Lamotte G, Rafferty MR, Prodoehl J, Kohrt WM, Comella CL, Simuni T, Corcos DM.
J Parkinsons Dis. 2015;5(1):21-41. doi: 10.3233/JPD-140425. Review. Erratum in: J Parkinsons Dis. 2015;5(4):993. J Parkinsons Dis. 2015;5(3):621.
Pub MED

Decline in verbal fluency after subthalamic nucleus deep brain stimulation in Parkinson's disease: a microlesion effect of the electrode trajectory?NUEVO

Le Goff F, Derrey S, Lefaucheur R, Borden A, Fetter D, Jan M, Wallon D, Maltête D.
J Parkinsons Dis. 2015;5(1):95-104. doi: 10.3233/JPD-140443.
Pub MED

Multidirectional walk test in individuals with Parkinson's disease: a validity study.NUEVO

Bryant MS, Workman CD, Jackson GR.
Int J Rehabil Res. 2015 Mar;38(1):88-91. doi: 10.1097/MRR.0000000000000091.
Pub MED

Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.NUEVO

Vivekanantham S, Shah S, Dewji R, Dewji A, Khatri C, Ologunde R.
Int J Neurosci. 2015;125(10):717-25. doi: 10.3109/00207454.2014.982795. Review.
Pub MED

Physical activity in advanced Parkinson's disease: impact of subthalamic deep brain stimulation.NUEVO

Daneault JF, Sadikot AF, Barbat-Artigas S, Aubertin-Leheudre M, Jodoin N, Panisset M, Duval C.
J Parkinsons Dis. 2015;5(1):85-93. doi: 10.3233/JPD-140426.
Pub MED

Kv4 channel blockade reduces motor and neuropsychiatric symptoms in rodent models of Parkinson's disease.NUEVO

Aidi-Knani S, Regaya I, Amalric M, Mourre C.
Behav Pharmacol. 2015 Feb;26(1-2):91-100. doi: 10.1097/FBP.0000000000000107.
Pub MED

Adaptive control of Parkinson's state based on a nonlinear computational model with unknown parameters.NUEVO

Su F, Wang J, Deng B, Wei XL, Chen YY, Liu C, Li HY.
Int J Neural Syst. 2015 Feb;25(1):1450030. doi: 10.1142/S0129065714500300.
Pub MED

Rapid eye movement sleep behavior disorder: a window on the emotional world of Parkinson disease.NUEVO

Mariotti P, Quaranta D, Di Giacopo R, Bentivoglio AR, Mazza M, Martini A, Canestri J, Della Marca G.
Sleep. 2015 Feb 1;38(2):287-94. doi: 10.5665/sleep.4416.
Pub MED

Protective effects of PEP-1-Catalase on stress-induced cellular toxicity and MPTP-induced Parkinson's disease.NUEVO

Eom SA, Kim DW, Shin MJ, Ahn EH, Chung SY, Sohn EJ, Jo HS, Jeon SJ, Kim DS, Kwon HY, Cho SW, Han KH, Park J, Eum WS, Choi SY.
BMB Rep. 2015 Jul;48(7):395-400.
Viendo del 1 al 40 de 2915 artículos
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy
Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.